Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arran Babbs

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2012
Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophyAurélie Goyenvalle, Jordan Wright, Arran Babbs, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense DeliveryAgathe Eckenfelder, Julie Tordo, Arran Babbs, et al.
Elife|November 3, 2015
Temporal transcriptomics suggest that twin-peaking genes reset the clockWilliam G Pembroke, Arran Babbs, Kay E Davies, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2009
Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapyAurélie Goyenvalle, Arran Babbs, Gert-Jan B van Ommen, et al.
Human Molecular Genetics|March 6, 2012
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skippingAurélie Goyenvalle, Arran Babbs, Jordan Wright, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skippingAurélie Goyenvalle, Arran Babbs, Dave Powell, et al.
Scientific Reports|March 3, 2017
Identification of serum protein biomarkers for utrophin based DMD therapySimon Guiraud, Benjamin Edwards, Sarah E Squire, et al.
Human Molecular Genetics|April 17, 2019
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophySimon Guiraud, Benjamin Edwards, Arran Babbs, et al.
Human Molecular Genetics|October 11, 2018
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMDSimon Guiraud, Benjamin Edwards, Sarah E Squire, et al.
Biochemical Society Transactions|June 30, 2020
From diagnosis to therapy in Duchenne muscular dystrophyArran Babbs, Maria Chatzopoulou, Ben Edwards, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2012
Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophyAurélie Goyenvalle, Jordan Wright, Arran Babbs, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense DeliveryAgathe Eckenfelder, Julie Tordo, Arran Babbs, et al.
Elife|November 3, 2015
Temporal transcriptomics suggest that twin-peaking genes reset the clockWilliam G Pembroke, Arran Babbs, Kay E Davies, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2009
Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapyAurélie Goyenvalle, Arran Babbs, Gert-Jan B van Ommen, et al.
Human Molecular Genetics|March 6, 2012
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skippingAurélie Goyenvalle, Arran Babbs, Jordan Wright, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skippingAurélie Goyenvalle, Arran Babbs, Dave Powell, et al.
Scientific Reports|March 3, 2017
Identification of serum protein biomarkers for utrophin based DMD therapySimon Guiraud, Benjamin Edwards, Sarah E Squire, et al.
Human Molecular Genetics|April 17, 2019
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophySimon Guiraud, Benjamin Edwards, Arran Babbs, et al.
Human Molecular Genetics|October 11, 2018
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMDSimon Guiraud, Benjamin Edwards, Sarah E Squire, et al.
Biochemical Society Transactions|June 30, 2020
From diagnosis to therapy in Duchenne muscular dystrophyArran Babbs, Maria Chatzopoulou, Ben Edwards, et al.
Pageof 2